Valuation: PeptiDream Inc.

Market Cap 131B 808M 708M 654M 604M 1.15B 77.34B 1.17B 7.86B 3.06B 37.85B 3.03B 2.97B P/E 2026 *
10.4x
P/E 2027 * 10.5x
Enterprise Value 102B 625M 548M 506M 468M 887M 59.87B 905M 6.09B 2.37B 29.3B 2.35B 2.3B EV / Sales 2026 *
2.27x
EV / Sales 2027 * 1.98x
Free-Float
72.4%
Yield 2026 *
-
Yield 2027 * 0.59%
1 week-2.57%
Current month-3.95%
1 month+2.10%
3 months-16.80%
6 months-41.07%
Current year-38.27%
1 week 1,003.5
Extreme 1003.5
1,066.5
1 month 916
Extreme 916
1,092
Current year 916
Extreme 916
1,788
1 year 916
Extreme 916
1,818.5
3 years 916
Extreme 916
3,060
5 years 916
Extreme 916
4,950
10 years 916
Extreme 916
6,540
Manager TitleAgeSince
Chief Executive Officer 51 01/01/2022
Chief Tech/Sci/R&D Officer - 01/04/2024
Chief Operating Officer - 02/07/2026
Director TitleAgeSince
Director/Board Member 51 01/08/2008
Director/Board Member 51 01/09/2017
Director/Board Member 55 01/03/2021
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-2.57%-35.10%-47.50% 808M
-1.28%-4.31%+69.81%+124.57% 56.71B
-2.45%-7.83%+63.92%+83.15% 51.3B
+3.27%+8.91%+21.21%+486.76% 25.26B
-0.81%-0.42%-16.24%-12.47% 23.65B
+3.70%+3.12%+42.78%-2.68% 18.69B
-0.53%+0.48%+37.29%-26.30% 17.71B
+2.34%+12.50%+224.02%+380.99% 17.7B
-1.34%+1.15%+35.22% - 14.26B
-1.70%+3.98%+28.96%+190.57% 14.1B
Average +0.12%+3.76%+47.19%+130.79% 24.02B
Weighted average by Cap. -0.32%+2.20%+57.03%+142.55%

Financials

2026 *2027 *
Net sales 44.71B 275M 241M 223M 206M 390M 26.32B 398M 2.68B 1.04B 12.88B 1.03B 1.01B 46.18B 284M 249M 230M 212M 403M 27.19B 411M 2.76B 1.07B 13.3B 1.07B 1.04B
Net income 12.76B 78.46M 68.82M 63.54M 58.71M 111M 7.51B 114M 764M 297M 3.68B 295M 288M 12.62B 77.56M 68.02M 62.8M 58.03M 110M 7.43B 112M 755M 293M 3.63B 291M 285M
Net Debt -29.67B -182M -160M -148M -137M -259M -17.47B -264M -1.78B -690M -8.55B -685M -670M -40.03B -246M -216M -199M -184M -349M -23.56B -356M -2.4B -931M -11.53B -924M -904M
Logo PeptiDream Inc.
PeptiDream Inc. is a Japan-based bio-venture company started by the University of Tokyo and principally engaged in the discovery and development of non-standard peptide therapeutics. The Company operates the Peptide Discovery Platform System (PDPS), a drug development platform system and conducts research and development (R&D) on new drug candidates based on the joint R&D with pharmaceutical companies in Japan and overseas. The Company is involved in the business centered on drug development based on special peptides. The Company's businesses include drug discovery joint R&D, PDPS technology loan (PDPS technology license) and expansion of its own pipeline through strategic alliance (strategic alliance or in-house drug discovery).
Employees
745
Date Price Change Volume
09/07/26 ¥1,022.50 0.00% 570,100
08/07/26 ¥1,022.50 -2.01% 836,100
07/07/26 ¥1,043.50 +0.34% 763,100
06/07/26 ¥1,040.00 +1.17% 845,700
03/07/26 ¥1,028.00 -2.05% 873,400
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
1,022.50JPY
Average target price
2,825.00JPY
Spread / Average Target
+176.28%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4587 Stock